A5026887827- Antifungal resistance and susceptibility
- Fungal Infections and Studies
- Infectious Diseases and Mycology
- Plant Pathogens and Fungal Diseases
- Asthma and respiratory diseases
- Respiratory and Cough-Related Research
- Nail Diseases and Treatments
- Sinusitis and nasal conditions
- Pneumocystis jirovecii pneumonia detection and treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Actinomycetales infections and treatment
- Allergic Rhinitis and Sensitization
- Bacterial Identification and Susceptibility Testing
- Fungal Biology and Applications
- Antimicrobial Resistance in Staphylococcus
- Antibiotic Use and Resistance
- Ocular Infections and Treatments
- Cystic Fibrosis Research Advances
- Mycobacterium research and diagnosis
- Infections and bacterial resistance
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Antibiotic Resistance in Bacteria
- Antimicrobial Peptides and Activities
- Liver Disease and Transplantation
- Pneumonia and Respiratory Infections
Central Drug Research Institute
2025
Academy of Scientific and Innovative Research
2025
Post Graduate Institute of Medical Education and Research
2015-2024
Chandigarh University
2009-2021
Advanced Medical Research Institute
2021
Canisius-Wilhelmina Ziekenhuis
2020
Institute of Medical Sciences
2020
Hawaii Department of Health
2019
United States Department of State
2019
Apollo Hospitals
2019
Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic disease, complicating many other respiratory disorders, thought to affect ~240 000 people in Europe. The most common form of CPA chronic cavitary (CCPA), which untreated may progress fibrosing aspergillosis. Less manifestations include: Aspergillus nodule single aspergilloma. All these entities are found non-immunocompromised patients with prior or current lung disease. Subacute invasive (formerly called necrotising...
During September-December 2020, we conducted a multicenter retrospective study across India to evaluate epidemiology and outcomes among cases of coronavirus disease (COVID-19)-associated mucormycosis (CAM). Among 287 patients, 187 (65.2%) had CAM; CAM prevalence was 0.27% hospitalized COVID-19 patients. We noted 2.1-fold rise in during the period compared with 2019. Uncontrolled diabetes mellitus most common underlying non-CAM only 32.6% COVID-19-related hypoxemia improper glucocorticoid use...
Zygomycosis is an emerging infection worldwide. A study was conducted to understand its spectrum in the Indian scenario. All patients diagnosed for invasive zygomycosis at a tertiary care center north India from 2000-2004, were retrospectively analyzed. total of 178 cases (mean average 35.6 cases/year) diagnosed. Rhino-orbito-cerebral type (54.5%) commonest presentation followed by cutaneous (14.6%), disseminated (9.0%), and gastrointestinal (8.4%) zygomycosis. Renal pulmonary seen 6.7%...
Mucormycosis due to Mucorales is reported at large numbers in uncontrolled diabetics across India, but systematic multicenter epidemiological study has not been published yet. The present prospective was conducted four major tertiary care centers of India (two north and two south India) during 2013–2015 compare the epidemiology, treatment strategies outcome mucormycosis between regions. Molecular techniques were employed confirm identity isolates or identify agent biopsy samples. A total 388...
To identify the risk factors associated with Candida auris candidaemia, as this fungus now poses a global threat.We performed subgroup analysis of previously reported study 27 Indian ICUs. The clinical data candidaemia cases due to C. and other species were compared determine significant infection.Of 1400 earlier, 74 (5.3%) from 19 ICUs . duration ICU stay prior diagnosis was significantly longer in patients (median 25, IQR 12-45 days) non- group 15, 9-28, P < 0.001). Based on logistic...
ABSTRACT Dermatophytosis, the commonest superficial fungal infection, has gained recent attention due to its change of epidemiology and treatment failures. Despite availability several agents effective against dermatophytes, incidences chronic reinfection, failures are on rise. Trichophyton rubrum interdigitale two species most frequently identified among clinical isolates in India. Consecutive patients ( n = 195) with suspected dermatophytosis during second half 2014 were included this...
Reports are increasing on the emergence of COVID-19-associated mucormycosis (CAM) globally, driven particularly by low- and middle-income countries. The recent unprecedented surge CAM in India has drawn worldwide attention. More than 28,252 cases counted is first country where been declared a notifiable disease. However, misconception management, diagnosing treating this infection continue to occur. Thus, European Confederation Medical Mycology (ECMM) International Society for Human Animal...